E4F1 deficiency results in oxidative stress-mediated cell death of leukemic cells

Journal of Experimental Medicine

Volumn 208, Issue 7, 2011, Pages 1403-1417

  Hatchi, Elodie ^a   Rodier, Genevieve ^a   Lacroix, Matthieu ^b   Caramel, Julie ^a   Kirsh, Olivier ^a   Jacquet, Chantal ^a   Schrepfer, Emilie ^b   Lagarrigue, Sylviane ^a   Linares, Laetitia Karine ^b   Lledo, Gwendaline ^b   Tondeur, Sylvie ^d   Dubus, Pierre ^c   Sardet, Claude ^a   Le Cam, Laurent ^a,b  

^a INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; E4F1 PROTEIN; PROTEIN; REACTIVE OXYGEN METABOLITE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL DEATH; CELL LINEAGE; CELL SURVIVAL; CONTROLLED STUDY; GENE DELETION; GENE OVEREXPRESSION; IN VIVO STUDY; LEUKEMIA CELL; LIFESPAN; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RECIPIENT; TUMOR REGRESSION; WILD TYPE;

EID: 79960361664     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20101995     Document Type: Article

References (52)

1. Ahmed-Choudhury, J., A. Agathanggelou, S.L. Fenton, C. Ricketts, G.J. Clark, E.R. Maher, and F. Latif. 2005. Transcriptional regulation of cyclin A2 by RASSF1A through the enhanced binding of p120E4F to the cyclin A2 promoter. Cancer Res. 65:2690-2697.
2. Berger, J.H., and N. Bardeesy. 2007. Modeling INK4/ARF tumor suppression in the mouse. Curr. Mol. Med. 7:63-75.
3. Carrasco, D.R., T. Fenton, K. Sukhdeo, M. Protopopova, M. Enos, M.J. You, D. Di Vizio, C. Nogueira, J. Stommel, G.S. Pinkus, et al. 2006. The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans. Cancer Cell. 9:379-390.
4. Chagraoui, J., S.L. Niessen, J. Lessard, S. Girard, P. Coulombe, M. Sauvageau, S. Meloche, and G. Sauvageau. 2006. E4F1: a novel candidate factor for mediating BMI1 function in primitive hematopoietic cells. Genes Dev. 20:2110-2120.
5. Colombo, R., G.F. Draetta, and S. Chiocca. 2003. Modulation of p120E4F transcriptional activity by the Gam1 adenoviral early protein. Oncogene. 22:2541-2547.
6. Crighton, D., S. Wilkinson, J. O'Prey, N. Syed, P. Smith, P.R. Harrison, M. Gasco, O. Garrone, T. Crook, and K.M. Ryan. 2006. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell. 126:121-134.
7. Dudziak, K., N. Mottalebi, S. Senkel, E.L. Edghill, S. Rosengarten, M. Roose, C. Bingham, S. Ellard, and G.U. Ryffel. 2008. Transcription factor HNF1beta and novel partners affect nephrogenesis. Kidney Int. 74:210-217.
8. Eischen, C.M., J.E. Rehg, S.J. Korsmeyer, and J.L. Cleveland. 2002. Loss of Bax alters tumor spectrum and tumor numbers in ARF-deficient mice. Cancer Res. 62:2184-2191.
9. Fajas, L., C. Paul, O. Zugasti, L. Le Cam, J. Polanowska, E. Fabbrizio, R. Medema, M.L. Vignais, and C. Sardet. 2000. pRB binds to and modulates the transrepressing activity of the E1A-regulated transcription factor p120E4F. Proc. Natl. Acad. Sci. USA. 97:7738-7743.
10. Fajas, L., C. Paul, A. Vié, S. Estrach, R. Medema, J.M. Blanchard, C. Sardet, and M.L. Vignais. 2001. Cyclin A is a mediator of p120E4F-dependent cell cycle arrest in G1. Mol. Cell. Biol. 21:2956-2966.
11. Fenton, S.L., A. Dallol, A. Agathanggelou, L. Hesson, J. Ahmed-Choudhury, S. Baksh, C. Sardet, R. Dammann, J.D. Minna, J. Downward, et al. 2004. Identification of the E1A-regulated transcription factor p120 E4F as an interacting partner of the RASSF1A candidate tumor suppressor gene. Cancer Res. 64:102-107.
12. Fernandes, E.R., J.Y. Zhang, and R.J. Rooney. 1998. Adenovirus E1Aregulated transcription factor p120E4F inhibits cell growth and induces the stabilization of the cdk inhibitor p21WAF1. Mol. Cell. Biol. 18:459-467.
13. Guerra, C., N. Mijimolle, A. Dhawahir, P. Dubus, M. Barradas, M. Serrano, V. Campuzano, and M. Barbacid. 2003. Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell. 4:111-120.
14. Huang, P., L. Feng, E.A. Oldham, M.J. Keating, and W. Plunkett. 2000. Superoxide dismutase as a target for the selective killing of cancer cells. Nature. 407:390-395.
15. Huang, Q., Y.T. Wu, H.L. Tan, C.N. Ong, and H.M. Shen. 2009. A novel function of poly(ADP-ribose) polymerase-1 in modulation of autophagy and necrosis under oxidative stress. Cell Death Differ. 16:264-277.
16. Kamijo, T., F. Zindy, M.F. Roussel, D.E. Quelle, J.R. Downing, R.A. Ashmun, G. Grosveld, and C.J. Sherr. 1997. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell. 91:649-659.
17. Khoo, C.M., D.R. Carrasco, M.W. Bosenberg, J.H. Paik, and R.A. Depinho. 2007. Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse. Proc. Natl. Acad. Sci. USA. 104:3931-3936.
18. Kim, W.Y., and N.E. Sharpless. 2006. The regulation of INK4/ARF in cancer and aging. Cell. 127:265-275.
19. Klaunig, J.E., L.M. Kamendulis, and B.A. Hocevar. 2010. Oxidative stress and oxidative damage in carcinogenesis. Toxicol. Pathol. 38:96-109.
20. Koopman, W.J., L.G. Nijtmans, C.E. Dieteren, P. Roestenberg, F. Valsecchi, J.A. Smeitink, and P.H. Willems. 2010. Mammalian mitochondrial complex I: biogenesis, regulation, and reactive oxygen species generation. Antioxid. Redox Signal. 12:1431-1470.
21. Lacroix, M., J. Caramel, P. Goguet-Rubio, L.K. Linares, S. Estrach, E. Hatchi, G. Rodier, G. Lledo, C. de Bettignies, A. Thépot, et al. 2010. Transcription factor E4F1 is essential for epidermal stem cell maintenance and skin homeostasis. Proc. Natl. Acad. Sci. USA. 107:21076-21081.
22. Le Cam, L., M. Lacroix, M.A. Ciemerych, C. Sardet, and P. Sicinski. 2004. The E4F protein is required for mitotic progression during embryonic cell cycles. Mol. Cell. Biol. 24:6467-6475.
23. Le Cam, L., L.K. Linares, C. Paul, E. Julien, M. Lacroix, E. Hatchi, R. Triboulet, G. Bossis, A. Shmueli, M.S. Rodriguez, et al. 2006. E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation. Cell. 127:775-788.
24. Lee, K.A., and M.R. Green. 1987. A cellular transcription factor E4F1 interacts with an E1a-inducible enhancer and mediates constitutive enhancer function in vitro. EMBO J. 6:1345-1353.
25. Lee, K.A., T.Y. Hai, L. SivaRaman, B. Thimmappaya, H.C. Hurst, N.C. Jones, and M.R. Green. 1987. A cellular protein, activating transcription factor, activates transcription of multiple E1A-inducible adenovirus early promoters. Proc. Natl. Acad. Sci. USA. 84:8355-8359.
26. Levine, B., and G. Kroemer. 2008. Autophagy in the pathogenesis of disease. Cell. 132:27-42.
27. Lund, A.H., G. Turner, A. Trubetskoy, E. Verhoeven, E. Wientjens, D. Hulsman, R. Russell, R.A. DePinho, J. Lenz, and M. van Lohuizen. 2002. Genomewide retroviral insertional tagging of genes involved in cancer in Cdkn2adeficient mice. Nat. Genet. 32:160-165.
28. Martín-Caballero, J., J.M. Flores, P. García-Palencia, and M. Serrano. 2001. Tumor susceptibility of p21(Waf1/Cip1)-deficient mice. Cancer Res. 61:6234-6238.
29. Mizushima, N. 2009. Physiological functions of autophagy. Curr. Top. Microbiol. Immunol. 335:71-84.
30. Nogueira, V., Y. Park, C.C. Chen, P.Z. Xu, M.L. Chen, I. Tonic, T. Unterman, and N. Hay. 2008. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell. 14:458-470.
31. Nojima, J., K. Kanomata, Y. Takada, T. Fukuda, S. Kokabu, S. Ohte, T. Takada, T. Tsukui, T.S. Yamamoto, H. Sasanuma, et al. 2010. Dual roles of smad proteins in the conversion from myoblasts to osteoblastic cells by bone morphogenetic proteins. J. Biol. Chem. 285:15577-15586.
32. Paul, C., M. Lacroix, I. Iankova, E. Julien, B.W. Schäfer, C. Labalette, Y. Wei, A. Le Cam, L. Le Cam, and C. Sardet. 2006. The LIM-only protein FHL2 is a negative regulator of E4F1. Oncogene. 25:5475-5484.
33. Quelle, D.E., F. Zindy, R.A. Ashmun, and C.J. Sherr. 1995. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell. 83:993-1000.
34. Radisky, D.C., D.D. Levy, L.E. Littlepage, H. Liu, C.M. Nelson, J.E. Fata, D. Leake, E.L. Godden, D.G. Albertson, M.A. Nieto, et al. 2005. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature. 436:123-127.
35. Raychaudhuri, P., R. Rooney, and J.R. Nevins. 1987. Identification of an E1A-inducible cellular factor that interacts with regulatory sequences within the adenovirus E4 promoter. EMBO J. 6:4073-4081.
36. Rizos, H., E. Diefenbach, P. Badhwar, S. Woodruff, T.M. Becker, R.J. Rooney, and R.F. Kefford. 2003. Association of p14ARF with the p120E4F transcriptional repressor enhances cell cycle inhibition. J. Biol. Chem. 278:4981-4989.
37. Rooney, R.J. 2001. Cell cycle attenuation by p120E4F is accompanied by increased mitotic dysfunction. Cell Growth Differ. 12:505-516.
38. Rui, E., P.R. Moura, K.A. Gonçalves, R.J. Rooney, and J. Kobarg. 2006. Interaction of the hepatitis B virus protein HBx with the human transcription regulatory protein p120E4F in vitro. Virus Res. 115:31-42.
39. Sandy, P., M. Gostissa, V. Fogal, L.D. Cecco, K. Szalay, R.J. Rooney, C. Schneider, and G. Del Sal. 2000. p53 is involved in the p120E4F-mediated growth arrest. Oncogene. 19:188-199.
40. Serrano, M., H. Lee, L. Chin, C. Cordon-Cardo, D. Beach, and R.A. DePinho. 1996. Role of the INK4a locus in tumor suppression and cell mortality. Cell. 85:27-37.
41. Sharpless, N.E., N. Bardeesy, K.H. Lee, D. Carrasco, D.H. Castrillon, A.J. Aguirre, E.A. Wu, J.W. Horner, and R.A. DePinho. 2001. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature. 413:86-91.
42. Struthers, L., R. Patel, J. Clark, and S. Thomas. 1998. Direct detection of 8-oxodeoxyguanosine and 8-oxoguanine by avidin and its analogues. Anal. Biochem. 255:20-31.
43. Sundström, C., and K. Nilsson. 1976. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer. 17:565-577.
44. Tasdemir, E., M.C. Maiuri, L. Galluzzi, I. Vitale, M. Djavaheri-Mergny, M. D'Amelio, A. Criollo, E. Morselli, C. Zhu, F. Harper, et al. 2008. Regulation of autophagy by cytoplasmic p53. Nat. Cell Biol. 10:676-687.
45. Tessari, M.A., M. Gostissa, S. Altamura, R. Sgarra, A. Rustighi, C. Salvagno, G. Caretti, C. Imbriano, R. Mantovani, G. Del Sal, et al. 2003. Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2. Mol. Cell. Biol. 23:9104-9116.
46. Trachootham, D., Y. Zhou, H. Zhang, Y. Demizu, Z. Chen, H. Pelicano, P.J. Chiao, G. Achanta, R.B. Arlinghaus, J. Liu, and P. Huang. 2006. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell. 10:241-252.
47. Trachootham, D., H. Zhang, W. Zhang, L. Feng, M. Du, Y. Zhou, Z. Chen, H. Pelicano, W. Plunkett, W.G. Wierda, et al. 2008. Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism. Blood. 112:1912-1922.
48. Valko, M., D. Leibfritz, J. Moncol, M.T. Cronin, M. Mazur, and J. Telser. 2007. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39:44-84.
49. Vousden, K.H., and K.M. Ryan. 2009. p53 and metabolism. Nat. Rev. Cancer. 9:691-700.
50. Xu, Y., S.O. Kim, Y. Li, and J. Han. 2006. Autophagy contributes to caspaseindependent macrophage cell death. J. Biol. Chem. 281:19179-19187.
51. Zhu, H., L. Zhang, K. Itoh, M. Yamamoto, D. Ross, M.A. Trush, J.L. Zweier, and Y. Li. 2006. Nrf2 controls bone marrow stromal cell susceptibility to oxidative and electrophilic stress. Free Radic. Biol. Med. 41:132-143.
52. Ziech, D., R. Franco, A. Pappa, and M.I. Panayiotidis. 2011. Reactive Oxygen Species (ROS)-Induced genetic and epigenetic alterations in human carcinogenesis. Mutat. Res. 711:167-173.